| New April 2005 Quarterly Average Sales Price (ASP) Medicare Part B Drug Pricing File and Revisions to January 2005 ASP Medicare Part B Drug Pricing File | ||||||
| Table 1 | ||||||
| Effective January 1, 2005 | ||||||
| HCPCS | Short Description | HCPCS Code Dosage | 1Q05 Payment Limit | 1Q05 Independent ESRD Limit | 1Q05 Vaccine Limit | 1Q05 Blood Limit |
| 90371 | Hep B ig, im | 1 ML | $ 115.878 | $ 115.878 | ||
| J2790 | Rho d immune globulin, inj | 300 MCG | $ 101.733 | $ 101.733 | ||
| J2792 | Rho (D) immune globulin, sd | 100 IU | $ 13.101 | $ 13.101 | ||
| Q0187 | NovoSeven | Per 1.2 MG | $ 1,211.050 | $ 1,211.050 | ||
| Table 2 | ||||||
| Effective April 1, 2005 | ||||||
| HCPCS | Short Description | HCPCS Code Dosage | 2Q05 Payment Limit | 2Q05 Independent ESRD Limit | 2Q05 Vaccine Limit | 2Q05 Blood Limit |
| 90747 | Hepb vacc, ill pat 4 dose im | 40 MCG | $ 113.915 | $ 113.915 | ||
| J0135 | Adalimumab injection | 20 MG | $ 294.632 | $ 294.632 | ||
| J0287 | Amphotericin b lipid complex | 10 MG | $ 11.724 | $ 11.724 | ||
| J0725 | Chorionic gonadotropin | 1000 UNITS | $ 2.976 | $ 2.976 | ||
| J2597 | Inj desmopressin acetate | 1 MCG | $ 2.493 | $ 2.493 | ||
| J7190 | Factor viii | I.U. | $ 0.641 | $ 0.641 | ||
| J7192 | Factor ix recombinant | I.U. | $ 1.063 | $ 1.063 | ||
| J7193 | Factor IX non-recombinant | I.U. | $ 0.882 | $ 0.882 | ||
| J7194 | Factor ix complex | I.U. | $ 0.650 | $ 0.650 | ||
| J7195 | Factor ix recombinant | I.U. | $ 0.982 | $ 0.982 | ||
| J7197 | Antithrombin iii injection | I.U. | $ 1.543 | $ 1.543 | ||
| J7198 | Anti-inhibitor | I.U. | $ 1.241 | $ 1.241 | ||
| J7344 | Nonmetabolic active tissue | 1 SQ CM | $ 52.777 | $ 52.777 | ||
| J9098 | Cytarabine liposome | 10 MG | $ 359.359 | $ 359.359 | ||
| J9245 | Inj melphalan hydrochl | 50 MG | $ 513.694 | $ 513.694 | ||
| J9266 | Pegaspargase single dose vial | 1 EA | $ 1,499.306 | $ 1,499.306 | ||
| P9041 | Albumin (human), 5% | 50 ML | $ 14.545 | $ 14.545 | $ 14.545 | |
| P9043 | Plama protein fraction, 5% | 50 ML | $ 14.545 | $ 14.545 | $ 14.545 | |
| P9046 | Albumin (human), 25% | 20 ML | $ 14.545 | $ 14.545 | $ 14.545 | |
| P9048 | Plama protein fraction, 5% | 250 ML | $ 29.099 | $ 29.099 | $ 29.099 | |
| Q0187 | NovoSeven | Per 1.2 MG | $ 1,228.438 | $ 1,228.438 | ||
| Q2002 | Elliotts b solution per ml | 1 ML | $ 3.350 | $ 3.350 | ||
| Q2005 | Corticorelin ovine triflutat | 1 EA | $ 379.067 | $ 379.067 | ||
| Q2012 | Pegademase bovine | 25 IU | $ 158.048 | $ 158.048 | ||
| Q2018 | Urofollitropin, 75 iu | 75 IU | $ 43.865 | $ 43.865 | ||
| Q9941 | IVIG lyophil | 1 G | $ 38.735 | $ 38.735 | ||
| Q9942 | IVIG lyophil | 10 MG | $ 0.387 | $ 0.387 | ||
| Q9943 | IVIG non-lyophil | 1 G | $ 56.221 | $ 56.221 | ||
| Q9944 | IVIG non-lyophil | 10 MG | $ 0.562 | $ 0.562 | ||
| Q9954 | Oral MR contrast | 100 ML | $ 8.844 | $ 8.844 | ||
| Please note J2910 is no longer included in the April 2005 pricing file. | ||||||
| The revised paymet limits in this notification supersede the payment limits for these codes in any | ||||||
| publication published prior to this document. Note that the absence or presence of a HCPCS code and | ||||||
| it's associated payment limit does not indicate Medicare coverage of the drug or biological. Similarly, the | ||||||
| inclusion of a payment limit within a specific column does not indicate Medicare coverage of the drug in | ||||||
| that specific category. The local Medicare contractor processing the claim shall make these determinations. | ||||||
| 5/26/2005 | ||||||
| CR 3846 | ||||||